• Shaping the future of pharma

  • Email: info@amarintech.com.ar

  • Contact Us

  • Home
  • About Us
    • Our History
    • Team Members
  • Services
    • Out Licensing
    • Co-Development
    • Development under contract
  • Portfolio
    • Technology
    • Pipeline
  • Blog
  • Contact
  • Let's talk info@amarintech.com.ar

Author: Florencia Cafisi

Amarin > Articles by: Florencia Cafisi
  • Florencia Cafisi
  • September 7, 2023December 9, 2025
  • Industry and Society

How do we control the quality of transdermal patches?

Transdermal patches present certain attributes that make the efficacy, safety, and quality of the product and must be controlled in the laboratory through analytical techniques to ensure the performance and safety of the transdermal delivery system (or TDS). Some of them correspond to tests that are common to other pharmaceutical [...]

Read More
  • Florencia Cafisi
  • October 13, 2022December 9, 2025
  • Industry and Society

New methylphenidate transdermal patch for Attention Deficit of Hyperactivity Disorder (ADHD) 

In October, we join to the awareness campaigns on ADHD by sharing this article that briefly describes the characteristics of transdermal system containing methylphenidate that has been recently developed by Amarin Technologies for the treatment of this condition. [...]

Read More
  • Florencia Cafisi
  • October 15, 2021December 9, 2025
  • Industry Challenges

Challenges in the analytical method transfer of transdermal pharmaceutical products

Although the analytical procedure transfer of transdermal pharmaceutical products follows the same general guidelines as other dosage forms, .. [...]

Read More

Categories

  • Development
  • Industry and Society
  • Industry Challenges
  • Laboratory
  • Research
  • Science
  • Technology
  • Transdermal Technology
  • Uncategorized
  • When the Delivery Format Is the ...
    April 7, 2026April 7, 2026
  • What the FDA’s new CTD quality ...
    March 11, 2026March 11, 2026
  • Smart biomaterials and nanotechnology
    February 9, 2026February 10, 2026
  • Dermocosmetic Patches
    Dermocosmetic patches, uses, and benefits
    July 29, 2025December 9, 2025

Feel Free to contact

  • Email Us info@amarintech.com.ar
  • Visit Us Sánchez 2043, Ciudad Autonóma de Buenos Aires, Argentina

Download Now

Download Pipeline download brochure

Tags

adhesive layer alzheimer Bacteria benefits bioequivalence computerized systems degenerative diseases dermocosmetics development drug delivery FDA industry innovation Intellectual Property inventory investigation Lab licensing strategy logistics market microbiome nanotechnology Oral Films CDMO oral thin film out-licensing parkinson patches pharma pharmaceutical partnerships pharma industry psychotropics quality quality assurance Regulation regulatory affairs Research Strategies to Deter Abuse in Transdermal Patches technology transdermal transdermal technology transportation

We are Skin Experts

Want To Explore A Transdermal Opportunity? We Can Help.
Let's talk

info@amarintech.com.ar

About Amarin

30+ Years Developing Customized Drug Delivery Solutions For Global Markets.

Follow us:

Links

  • About Us
  • Services
  • Portfolio

Recent Posts

  • April 7, 2026April 7, 2026
    When the Delivery Format Is the Product: The ...
  • March 11, 2026March 11, 2026
    What the FDA’s new CTD quality guidance means ...

Contact info:

  • Sánchez 2043, Ciudad Autonóma de Buenos Aires, Argentina

  • info@amarintech.com.ar

Suscribe now

Developed by: SiberiaLAB

© Amarin Tech 2025 | All Right Reserved

ES